Hard-to-treat pancreatic cancer hijacks immune system and could be targeted with immunotherapies 03 Sep 2020 Scientists have used artificial intelligence to reveal an aggressive form of pancreatic cancer that is more likely to respond to immunotherapy, in the most extensive analysis of the immune landscape of these tumours to date. Find out more Show/Hide
ICR researchers working with Imperial College London to investigate medical cannabis for cancer and acute pain 15 Oct 2019 Imperial College London researchers are trialling cannabis-based medicinal products for the treatment of cancer and acute pain. The researchers are collaborating with medical cannabis company EMMAC Life Sciences and The Institute of Cancer Research, London, to better understand the effectiveness of the products. Find out more Show/Hide
Artificial intelligence reveals new breast cancer types that respond differently to treatment 02 Aug 2019 Scientists have used artificial intelligence to recognise patterns in breast cancer – and uncovered five new types of the disease, each matched to different personalised treatments. Find out more Show/Hide
Partnering to Defeat Cancer: Babraham Research Campus hosts ICR networking event for our scientists and potential new commercial partners 21 Jan 2019